Although an increasing number of nuclear orphan receptors have recently been identified, the number of known naturally occurring genes that are directly regulated by orphan receptors is still small. We have shown previously that the gene encoding the neuropeptide oxytocin (OT) is negatively regulated by the orphan receptors chicken ovalbumin upstream transcription factor I (COUP-TFI) and II. Here we show that the mouse OT gene promoter is activated by ROR , a representative of the ROR/RZR orphan receptor subfamily. Using promoter/chloramphenicol acetyltransferase reporter constructs in heterologous transfection assays, we determined that ROR action induces a <6-fold increase in promoter activity. By 5 and 3 deletion analysis, DNase footprint analysis and electrophoretic mobility shift assays, we found that ROR action is mediated by two 14 bp regions centered at 160 and 180 nucleotides upstream of the transcriptional initiation site. Both sites contain significant sequence identities with an established ROR recognition sequence. Mutations in either or both of these sites reduce significantly RORinduced activation of the OT promoter. In view of the strong transcriptional activation exerted by ROR on the OT gene promoter and the widespread distribution of different members of the ROR/RZR family, interactions between ROR/RZR isoforms and the OT gene may form part of the multifactorial regulatory mechanisms that control OT gene expression in different tissues.
INTRODUCTION
The nonapeptide hormone oxytocin (OT) acts as a neurotransmitter as well as a peripheral hormone. Whereas central effects of OT involve induction of specific reproductive behaviors, peripheral effects include uterine contractions, milk ejection, natriuresis and vasodilation (Zingg 1996 , Thibonnier et al. 1999 . Centrally, the OT gene is expressed in specific hypothalamic neuroendocrine cells as well as in the pineal gland (Milcu et al. 1963 , Fisher & Fernstrom 1981 , Liu & Burbach 1987 . Peripherally, the gene is expressed in uterine epithelium (Lefebvre et al. 1992) , fetal membranes (Mitchell et al. 1998 ) and the corpus luteum (Ivell et al. 1998) . OT gene expression is hormonally induced by estrogen and retinoic acid (Larcher et al. 1995) . In addition, we and others have shown that orphan nuclear receptors, specifically members of the chicken ovalbumin upstream transcription factor (COUP-TF) family, antagonize hormonemediated transcriptional activation of the OT gene and actively silence the OT gene promoter (Burbach et al. 1994 ). These nuclear receptor/promoter interactions are mediated by a well-conserved region centered at 160 relative to the transcriptional initiation site (Richard & Zingg 1990 , Adan et al. 1993 . This region was initially identified as an estrogen response element (ERE) (Richard & Zingg 1991) and is here referred to as OT/ERE.
In the present study, we have examined the role of the recently identified orphan receptor ROR in the regulation of the OT promoter. The ROR/RZR subfamily of orphan nuclear receptors is a recent addition to the nuclear receptor family and comprises the following members: ROR 1, ROR 2, ROR 3, ROR /RZR and ROR , Giguère et al. 1994 , Hirose et al. 1994 . The members of this subfamily bind as monomers preferentially to an AGGTCA core motif preceded by an A/T-rich region (Giguère et al. 1994) . Although the expression pattern of this receptor family is quite ubiquitous, high expression of specific members is observed in certain tissues. Thus, ROR 1 is highly expressed in Purkinje cells of the mouse cerebellum (Matsui et al. 1995) , and a mutation in the ROR 1 gene gives rise to the staggerer mouse phenotype (Hamilton et al. 1996 , Dussault et al. 1998 . ROR /RZR is abundantly expressed in the hypothalamus, the pineal gland and the thalamus . ROR is highly expressed in skeletal muscle and may play a role in muscle development (Hirose et al. 1994) .
Although structural information on the orphan receptor superfamily is rapidly expanding, relatively few genes have been identified that are directly regulated by orphan receptors. Identified target genes for members of the ROR/RZR family include the gene for F-crystallin, apoliprotein A-I, 5-lipoxygenase, cellular retinol-bindingl protein, retinoic acid receptor-, p21
WAF/CIP1 and Purkinje cell protein-2 (Steinhilber et al. 1995 , Tini et al. 1995 , Schräder et al. 1996 , Vu-Dac et al. 1997 ).
Here we report that the mouse OT gene represents a novel target for ROR receptors by demonstrating that its promoter is strongly stimulated by ROR via a DNA element that has been conserved throughout species evolution.
MATERIALS AND METHODS

Plasmids
Plasmid p1064CAT contained nucleotides 1064 to +38 of the mouse OT promoter (Hara et al. 1990) linked to the gene encoding chloramphenicol acetyltransferase (CAT). The deletion mutants p428CAT, p225CAT, p118CAT and p42CAT were derived from p1064CAT. p225 OT/ERE, p225 HS1 and p225 mutants were obtained by site-directed mutagenesis (Kunkel 1985) . The mutagenic oligonucleotides were also used in the gel shift assays (see below). Plasmids p225/118-TATA-CAT and p134/34-TATA-CAT contained fragments 225 to 118 and 134 to 34 respectively of the mouse OT 5 -flanking region linked to a TATA-box derived from the adenovirus 1b followed by the gene encoding CAT. The parent plasmid -CAT containing the TATA-box linked to the CAT gene was obtained from Dr V Giguère, (Royal Victoria Hospital, McGill University, Montreal) . All constructs were verified by dideoxynucleotide sequencing. Expression vectors CMX and CMX-ROR 1 were also obtained from Dr Giguère (Giguère et al. 1994) . These contained a cytomegalovirus-derived promoter which, in CMX-ROR 1, was linked to a cDNA encoding mouse ROR 1. The vector HSP--gal contained a heat shock protein (HSP) gene-derived promoter linked to the -galactosidase gene (obtained from Dr Giguère).
Transfections
Mouse Neuro-2a cells (American Type Culture Collection, Rockville, MD, USA; line CCL 131) were maintained in Eagle's minimum essential medium (EMEM; Sigma, St Louis, MI, USA) supplemented with 10% fetal bovine serum (GIBCO, Rockville, MD, USA). Cells were plated on 60 mm dishes and allowed to reach 70-80% confluency before transfection. Plasmids used in transfection studies were purified twice by ultracentrifugation through 5·2 M cesium chloride. Each plate was transfected with a total of 10 µg DNA, including 5 µg CAT reporter plasmid, 3 µg expression vectors, 100 ng HSP-galactosidase plasmid and 1·9 µg pBluescript plasmid KS(+). Transfection was performed by the calcium phosphate precipitation technique. After 4 h of incubation with the precipitate, a glycerol shock was applied by incubating cells in a buffered saline solution containing 15% glycerol for 2·5 min. Cells were then washed with PBS and cultured in EMEM/10% fetal bovine serum. Forty-eight hours after the transfection, cells were collected and CAT activity was determined, using a phase extraction method (Seed & Sheen 1988) . Unless stated otherwise, transfections were performed in duplicates at least three times. CAT activity was normalized with respect to -gal activity recovered from cell extracts. Cotransfection with the ROR 1 expression vector remained without effect on the transcriptional activity of the HSP--gal expression vector.
Bacterial expression of proteins
Recombinant human ROR 1 and rat COUP-TFII were produced in BL21 cells as glutathione-Stransferase (GST)-fusion proteins. The cDNAs encoding human ROR 1 or rat COUP-TFII were amplified by PCR and inserted in-frame with the GST-coding region in the bacterial expression plasmid pGEXKG (Novagen, Madison, WI, USA). The resulting plasmid was used to transform BL21 cells as described (Novagen). Cells were grown until they reached an OD 550 of 0·6 and Isopropyl--Dthiogalactopyranoside (IPTG) was added to a final concentration of 0·1 mM. Three hours after IPTG induction, cells were collected and purified using a glutathione resin (Pharmacia, Uppsala, Sweden), according to the manufacturer's instructions. Finally, the GST moiety was removed by thrombin cleavage
DNAse I footprinting assays
Probes for DNAse footprinting experiments were generated by PCR. The primer pair used for the amplification reaction consisted of oligonucleotide R48 (complementary to a part of the pBluescript polylinker region, sense strand direction) and a reverse primer complementary to the 5 -end of the CAT cDNA (anti-sense direction). The oligonucleotide R48 was labeled with 32 P using [ 32 P] ATP and T4 polynucleotide kinase. For the PCR reaction, p225CAT was used as a template in conjunction with 10 pmol of each primer. Following 35 cycles of amplification (94 C, 1 min; 58 C, 1 min; 72 C, 1 min) the PCR product was gel purified and diluted to 10 000 c.p.m./ml. For DNase I footprinting analysis, 0·06-5 ml of recombinant protein were incubated with 10 000 c.p.m. DNA probe in binding buffer (12 mM Hepes (pH 7.9) 12% glycerol, 70 mM KCl, 3 mM MgCl 2 , 250 ng poly(dI-dC); Pharmacia). Following incubation of the binding reaction for 30 min at room temperature, 0·25 unit of DNAse I (RQ1-DNase I, Promega, Madison, WI, USA) was added for 90 s. The endonuclease reaction was stopped by the addition of EDTA to a final concentration of 5 mM. The binding reaction was phenol extracted, precipitated with ethanol and resuspended in 90% formamide loading buffer. Equal amounts of recovered probe were then loaded on a 10% denaturating polyacrylamide gel.
Electrophoretic mobility shift assay (EMSA)
For EMSAs, in vitro translated CMX or CMX-ROR 1 was used. Translation products were obtained in vitro by using plasmids CMX or CMX-ROR as templates in an in vitro transcription/translation reaction mix (TNT lysate, Promega) according to the manufacturer's instruction. All proteins were [ 35 S]methionine labeled and their sizes verified by electrophoresis in 10% SDS-polyacrylamide gels.
Ten picomoles double-stranded oligonucleotides were labeled using T4 kinase and [ 32 P] ATP. Two milliliters of in vitro translated ROR 1 were incubated in binding buffer with 10 fmol probe for 30 min at room temperature and electrophoresed on a non-denaturating 4% polyacrylamide gel in 0·25 TBE buffer at 150 V. A polyclonal antibody against rat ROR 1 was obtained from Dr V Giguère (Dussault et al. 1998) .
RESULTS
We tested the effect of ROR 1, a member of the family of orphan receptors, on OT promoter activity by transfecting 5 deletion mutants of mouse OT-CAT reporter plasmids in mouse Neuro-2a cells in conjunction with an expression plasmid for ROR 1 (CMX-ROR 1). With the longest reporter construct used (p1064CAT), cotransfection of the ROR 1 expression vector CMX-ROR 1 led to a 6-to 7-fold increase in CAT activity compared with cells transfected with the parental plasmid CMX (Fig. 1) . Similar or greater activation was also observed with shorter constructs (p428CAT and p225CAT). However, with the construct p118CAT, ROR 1 elicited only a 2·2-fold increase in activity. No significant activation was observed with the construct p42CAT. These studies indicate that the sequence interval 225 and 42 harbors a region involved in conferring inducibility by ROR .
To delineate further the 3 -end of the area mediating this response, regions 225 to 118 (p225/118TATA-CAT) and 134 to 34 (p134/ 34TATA-CAT) were cloned upstream of a minimal adenovirus 1b TATA-box/CAT reporter and transfected in Neuro-2a cells (Fig. 2) . Cotransfection of ROR 1 elicited a strong 14-fold increase in CAT activity mediated by the construct p225/ 118TATA-CAT. Only a very weak effect was observed with p134/42TATA-CAT or the parental reporter construct ( -CAT). These results narrow the area mediating activation by ROR 1 further down to the region 225 to 118.
DNAse I footprinting with bacterially expressed ROR 1 was used to identify more precisely the regions involved in ROR 1 binding. Two adjacent regions were found to be resistant to DNAse I digestion following incubation with ROR 1 (Fig. 3) . One region was centered at position 180 and the other at position 160. The first region ( 188 to 174) includes the sequence element AGGTCA. As shown by Umesono et al. (1991) , this element forms the building block of several types of nuclear receptor response elements (see Discussion). The second region encompasses the OT/ERE and contains three AGGTCA-related motifs, which can be viewed either as an inverted repeat (HS2 and HS3) or as a direct repeat (HS3 and HS4) (Fig. 4A) . The center of the footprint appeared to be located over HS4 (Fig. 3) .
For comparison, the binding of the orphan receptor COUP-TFII to this same promoter area was also examined. COUP-TFII is a prototype for dimer binding. We have previously shown that COUP-TFII binds to the human OT/ERE . Lane 4 in Fig. 3 shows that bacterially
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Journal of Molecular Endocrinology (1999) 23, 337-346 expressed COUP-TFII also binds to the mouse OT/ERE and HS1, but the regions protected by COUP-TFII are larger than the ones protected by ROR 1. This is compatible with the accepted concept that COUP-TF binds as a dimer, whereas ROR binds as a monomer. Indeed, COUP-TF homodimers have been shown to bind with high affinity to monomeric ROR/RZR response elements (Schräder et al. 1996) . In addition, COUP-TFII is also able to bind to a more downstream area ( 75 to 100) containing three (inverted) GGTCA repeats (Fig. 3) as demonstrated earlier for the human gene . A noticeable but weak footprint is also formed by ROR in this region.
EMSA was performed to further characterize ROR 1 binding to the OT/ERE and the HS1. In vitro translated ROR 1 protein was incubated with oligonucleotides encompassing either the OT/ERE (Fig. 4B) or the HS1 (Fig. 4C) . ROR 1 readily bound specifically to the OT/ERE (Fig. 4B, lanes  3-6) . In contrast to the wild-type OT/ERE oligonucleotide, an oligonucleotide carrying a mutated OT/ERE ( OT/ERE) was unable to compete for binding (lanes 4-6 vs 7-9). ROR 1 binding to the OT/ERE probe was also competed by an oligonucleotide containing HS1 (lanes 10-12) . The consensus RORE represented an even stronger competitor. Whereas a 25-fold excess of cold RORE oligonucleotide readily competed away binding of the OT/ERE or the HS1 probes, a 100-fold excess of homologous cold probe was required to observe the same effect ( Fig. 4B and C) .
We next tested mutations that abrogate ROR binding with respect to their effect on promoter function. The construct p255 OT/ERE-CAT carried the mutation present in the oligonucleotide OT/ERE used in the EMSA studies above. Similarly, the mutations in construct p225 HS1-CAT corresponded to the mutations in the  2. The region 225 to 118 of the OT promoter is sufficient for ROR 1-mediated activation. (A) Schematic diagram of constructs used. Regions 225 to 118 (p225/118TATA-CAT) and 134 to 34 (p134/34TATA-CAT) were cloned upstream of the adenovirus 1b TATA-box and transfected into Neuro-2a cells together with the vector CMX or CMX-ROR 1. (B) CAT activity was normalized with respect to -gal activity and was expressed as fold induction observed in CMX-ROR -transfected cells over CMX-transfected cells, as in Fig. 1 . Each bar represents the mean .. of three or more independent experiments, each performed in duplicate.
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Journal of Molecular Endocrinology (1999) 23, 337-346 oligonucleotide HS1. Finally, the construct p255 CAT contained the combined mutations of HS1 and OT/ERE. Whereas wild-type p225CAT activity was stimulated 9-fold by ROR 1, the mutant p225 OT/ERE-CAT was only stimulated 4-fold (Fig. 5) . Similarly, construct p225 HS1-CAT was only induced 3-fold (Fig. 5) . Introduction of a double mutation (p225 -CAT) led to a further decrease in inducibility to about 2-fold. These results suggest that the OT/ERE and the HS1 sites both contribute additively, but not synergistically, to ROR 1-mediated induction.
DISCUSSION
We and others have shown that selected members of the nuclear receptor family are potent regulators of OT expression. This includes the nuclear receptors for estrogens, retinoids and thyroid hormone, as well as the orphan receptors COUP-TFI, COUP-TFII, Erb-A-related receptor 2 (Ear-2) and steroidogenic factor 1 (SF-1) (Richard & Zingg 1990 , 1991 , Adan et al. 1992 , 1993 , Burbach et al. 1994 , Wehrenberg et al. 1994 ). Here we demonstrate that a member of the orphan receptor family ROR/RZR acts as a regulator of OT expression. In contrast to all other orphan receptors that have so far been shown to act as inhibitors or, in the case of SF-1, as only weak activators of the OT gene promoter (Wehrenberg et al. 1994) , ROR 1 acts as a strong activator of the OT gene promoter.
We have demonstrated that the OT promoter is stimulated by the orphan receptor ROR 1 via a small region of the promoter which can be transferred to a heterologous adenovirus 1b TATA promoter. This small region contains the conserved OT/ERE and an AGGTCA half-site (HS1) located 5 of the OT/ERE. Mutation of any of these elements leads to reduced activation by ROR 1. In addition, using DNase I footprinting and EMSA experiments, ROR 1 was shown to bind specifically to these two elements.
By PCR-mediated site selection, Giguère et al. (1994) have determined a consensus sequence for ROR 1 binding as follows: (Fig. 6) . The OT/ERE contains three half-sites, HS2, HS3 and HS4 (Fig. 6) . According to the results from our footprinting studies, HS4 seems to be preferentially recognized by ROR 1. Comparison of HS4 with the consensus ROR 1-binding site indicates that, in addition to the conserved AGGTCA half-site, nucleotides 1, 2 and 3 preceding the AGGTCA also conform to the consensus binding site (Fig. 6 ). Nucleotide 4, however, differs from the consensus sequence.
Comparison of the HS1 with the consensus ROR 1-binding site reveals that positions 2, 3, 4 and 6 relative to the AGGTCA motif all conform to the consensus sequence. Of note is the presence of a C at position 2 which is conserved throughout in the OT/ERE, the HS1 and the ROR 1 consensus binding sequence.
Mutation of the OT/ERE or HS1 that abolished binding to ROR 1 reduced ROR 1-mediated induction by 56 and 68% respectively and a combined mutation of both the OT/ERE and the HS1 lowered the induction by 76% (Fig. 5B) . The residual activity of the double mutant is probably due to the downstream AGGTCA repeats, a region which is also weakly protected in the DNAse I footprinting assay.
It remains to be determined to what extent other members of the ROR/RZR family have the same or similar effects on OT gene promoter activity. Studies by Carlberg et al. (1994) indicate that ROR 1 and ROR /RZR have indistinguishable binding characteristics and suggest considerable functional overlap between these ROR/RZR isoforms. In view of the expanding list of isoforms present in the ROR/RZR family and the widespread distribution of these members, it is conceivable that interactions similar to the one characterized here for the case of ROR 1 may take place in different OT-expressing tissues, involving different ROR/ RZR isoforms. The strong, ligand-independent activation function of ROR 1 demonstrated here suggests that ROR may form an important part of the multifactorial regulatory mechanisms that control the neuronal and non-neuronal expression of the OT gene.
